<DOC>
	<DOC>NCT02666261</DOC>
	<brief_summary>This non-interventional study will collect data from routine diagnostics on HER2 testing of breast cancer in Germany.</brief_summary>
	<brief_title>A Study on the Epidemiology and Testing of Human Epidermal Growth Factor-Receptor 2 (HER2) in Breast Cancer in Germany</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>Samples derived from men and women of age greater than or equal to (&gt;/=) 18 years Samples derived from participants with any stage of histologically confirmed invasive breast cancer with HER2 diagnostics performed within routine (histo)pathological workup or (Histo)Pathological workup of the tumor sample as at or after start of this study Available information on the year of birth of the participant No preselection of tumor samples is allowed. Tumor samples have to be documented consecutively in the order of their (histo)pathological workup. Sample derived from participants with any stage of breast cancer with no HER2 diagnostics performed at the time of routine (histo)pathological workup. Samples derived prior to the start of this study.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>